(GINA) 2006 - Global Initiative for Asthma

42. Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M,
Edwards L,et al. Low-dose inhaled fluticasone propionate versus
oral zafirlukast in the treatment of persistent asthma. J Allergy Clin
Immunol 2000;105(6 Pt 1):1123-9.
43. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I,
et al. Montelukast added to inhaled beclomethasone in treatment of
asthma. Montelukast/Beclomethasone Additivity Group. Am J
Respir Crit Care Med 1999;160(6):1862-8.
44. Lofdahl CG, Reiss TF, Leff JA, Israel E, Noonan MJ, Finn AF, et al.
Randomised, placebo controlled trial of effect of a leukotriene
receptor antagonist, montelukast, on tapering inhaled
corticosteroids in asthmatic patients. BMJ 1999;319(7202):87-90.
45. Virchow JC, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast
improves asthma control in patients receiving high-dose inhaled
corticosteroids. Am J Respir Crit Care Med 2000;162(2 Pt 1):578-85.
46. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG,
et al. Randomised controlled trial of montelukast plus inhaled
budesonide versus double dose inhaled budesonide in adult
patients with asthma. Thorax 2003;58(3):211-6.
47. Vaquerizo MJ, Casan P, Castillo J, Perpina M, Sanchis J, Sobradillo
V, et al. Effect of montelukast added to inhaled budesonide on
control of mild to moderate asthma. Thorax 2003;58(3):204-10.
48. Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP,
Haahtela T, et al. Montelukast and fluticasone compared with
salmeterol and fluticasone in protecting against asthma
exacerbation in adults: one year, double blind, randomised,
comparative trial. BMJ 2003;327(7420):891.
49. Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K,
et al. Fluticasone propionate/salmeterol combination provides more
effective asthma control than low-dose inhaled corticosteroid plus
montelukast. J Allergy Clin Immunol 2000;106(6):1088-95.
50. Fish JE, Israel E, Murray JJ, Emmett A, Boone R, Yancey SW, et al.
Salmeterol powder provides significantly better benefit than
montelukast in asthmatic patients receiving concomitant inhaled
corticosteroid therapy. Chest 2001;120(2):423-30.
51. Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M, et
al. The salmeterol/fluticasone combination is more effective than
fluticasone plus oral montelukast in asthma. Respir Med
2003;97(3):234-41.
52. Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker A,
Haranath SP, et al. Churg-Strauss syndrome in patients receiving
montelukast as treatment for asthma. Chest 2000;117(3):708-13.
53. Wechsler ME, Pauwels R, Drazen JM. Leukotriene modifiers and
Churg-Strauss syndrome: adverse effect or response to
corticosteroid with drawal? Drug Saf 1999;21(4):241-51.
54. Harrold LR, Andrade SE, Go AS, Buist AS, Eisner M, Vollmer WM, et
al. Incidence of Churg-Strauss syndrome in asthma drug users: a
population-based perspective. J Rheumatol 2005;32(6):1076-80.
55. Lemanske RF, Jr., Sorkness CA, Mauger EA, Lazarus SC, Boushey
HA, Fahy JV, et al. Inhaled corticosteroid reduction and elimination
in patients with persistent asthma receiving salmeterol: a
randomized controlled trial. JAMA 2001;285(20):2594-603.
56. Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF, Jr.,
Sorkness CA,et al. Long-acting beta2-agonist monotherapy vs
continued therapy with inhaled corticosteroids in patients with
persistent asthma: a randomized controlled trial. JAMA
2001;285(20):2583-93.
57. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL,
Kemp JP, et al. A comparison of salmeterol with albuterol in the
treatment of mild-to- moderate asthma. N Engl J Med
1992;327(20):1420-5.
58. Kesten S, Chapman KR, Broder I, Cartier A, Hyland RH, Knight A, et
al. A three-month comparison of twice daily inhaled formoterol
versus four times daily inhaled albuterol in the management of
stable asthma. Am Rev Respir Dis 1991;144(3 Pt 1):622-5.
59. Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, et
al. Efficacy, safety, and effects on quality of life of salmeterol versus
albuterol in patients with mild to moderate persistent asthma. Ann
Allergy Asthma Immunol 1998;80(6):463-70.
60. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose
of inhaled steroid or addition of salmeterol in symptomatic asthma
(MIASMA). BMJ 2000;320(7246):1368-73.
61. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of
addition of salmeterol to inhaled steroids with doubling of the dose
of inhaled steroids. Am J Respir Crit Care Med 1996;153(5):1481-8.
62. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol
versus higher-dose corticosteroid in asthma patients with symptoms
on existing inhaled corticosteroid. Allen & Hanburys Limited UK
Study Group. Lancet 1994;344(8917):219-24.
63. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ,
Pauwels RA, et al. Can guideline-defined asthma control be
achieved? The Gaining Optimal Asthma ControL study. Am J Respir
Crit Care Med 2004;170(8):836-44.
64. Lalloo UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen
B, et al. Budesonide and formoterol in a single inhaler improves
asthma control compared with increasing the dose of corticosteroid
in adults with mild-to-moderate asthma. Chest 2003;123(5):1480-7.
65. Kips JC, O'Connor BJ, Inman MD, Svensson K, Pauwels RA,
O'Byrne PM. A long-term study of the antiinflammatory effect of
low-dose budesonide plus formoterol versus high-dose budesonide
in asthma. Am J Respir Crit Care Med 2000;161(3 Pt1):996-1001.
66. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza
Rosenzweig JR. Improved refill persistence with fluticasone
propionate and salmeterol in a single inhaler compared with other
controller therapies. J Allergy Clin Immunol 2004;113(2):245-51.
67. Rabe KF, Pizzichini E, Stallberg B, Romero S, Balanzat AM, Atienza
T, et al. Budesonide/formoterol in a single inhaler for maintenance
and relief in mild-to-moderate asthma: a randomized, double-blind
trial. Chest 2006;129(2):246-56.
68. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu
Y, et al. Budesonide/formoterol combination therapy as both
maintenance and reliever medication in asthma. Am J Respir Crit
Care Med 2005;171(2):129-36.
69. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni
S, et al. Efficacy and safety of budesonide/formoterol single inhaler
therapy versus a higher dose of budesonide in moderate to severe
asthma. Curr Med Res Opin 2004;20(9):1403-18.
70. Vogelmeier C, D'Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S,
et al. Budesonide/formoterol maintenance and reliever therapy: an
effective asthma treatment option? Eur Respir J 2005;26(5):819-28.
71. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden
ER, Jr. Effect of long-term salmeterol treatment onexercise-induced
asthma. N Engl J Med 1998;339(3):141-6.
TRATTAMENTO DELL’ASMA 43